Roche builds gene therapy portfolio with SpliceBio deal

Roche builds gene therapy portfolio with SpliceBio deal

Submitted by admin on October 17, 2023 - 11:00am
Source: 
Pharmaphorum
News Tags: 
Roche
Spark Therapeutics
SpliceBio
gene therapy
inherited retinal disease
Headline: 
Roche builds gene therapy portfolio with SpliceBio deal
snippet: 

Roche’s gene therapy unit Spark has added to its pipeline in inherited retinal diseases (IRDs) with a $216 million alliance with Spanish biotech SpliceBio.

Do Not Allow Advertisers to Use My Personal information